Investigating and Characterizing the Immune Response to Prostate Cancer
Completed · Not applicable
Conditions studied: Prostate Cancer
In brief
This study is a clinical study to investigate and characterize the immune response profile to four different prostate cancer treatments (total cryotherapy, focal cryotherapy, Cyberknife SBRT, and radical prostatectomy) in patients with localized prostate cancer.
Key facts
- Study ID
- NCT03331367
- Run by
- NYU Langone Health
- People needed
- 40
- Starts
- 2017-09-14
- Expected to finish
- 2020-02-25
- Last updated by the study team
- 2020-08-07
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Patient is willing and able to freely sign informed consent to enroll in the study.
- Histologically proven Prostate Carcinoma.
- Undergoing total cryotherapy, focal cryotherapy, Cyberknife SBRT or radical prostatectomy for prostate cancer treatment.
You may not qualify if…
- Has previously had a radical prostatectomy for prostate cancer.
- Has previously received cryotherapy for prostate cancer.
- Previous treatment with chemotherapy within the past 6 months.
- Previous treatment with radiation within the past 18 months.
- Has evidence of metastatic disease.
- Has a current or history within the past 6 months of alcohol and/or substance abuse which would impair participation in the study.
- Has a major medical disorder (i.e. uncontrolled diabetes, significant hepatic, renal or hematological disorders, recent stroke or myocardial infarction), in the opinion of the urologist, is an illness or complication which is not consistent with the protocol requirements.
- Is not willing to undergo the necessary follow-up for the trial period.
- Has known immunologic disease, human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness.
Where it is running
- NYU Winthrop Hospital — Mineola, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.